永远不会放弃你 - - 联蛋白激酶抑制剂的当前发展
Laura Hillebrand1, Matthias Gehringer2,3
1Department of Pharmaceutical & Medicinal Chemistry, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany. laura.hillebrand@uni-tuebingen.de.
Chimia
|December 9, 2023
概括
向蛋白激酶的共价抑制剂正在迅速发展. 本综述涵盖了不可逆和可逆的抑制剂,包括药物开发的新策略,超出了氨酸向.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 生物化学 生物化学
背景情况:
- 共价抑制剂正在医学化学中重新获得突出地位.
- 向蛋白质激酶,一种主要的可药物治疗蛋白质家族,已经成功地使用了与非催化氨酸残留物接触的抑制剂.
- 弱反应电友是这种成功准策略的关键.
研究的目的:
- 提供对目前正在临床开发中的共价蛋白激酶抑制剂的全面概述.
- 突出新兴的策略,以准除氨酸以外的氨基酸.
- 审查在共价蛋白激酶抑制剂的设计中使用的反应组.
主要方法:
- 对临床和临床前共价蛋白激酶抑制剂的文献综述.
- 分析超出氨酸残留物的向策略.
- 在抑制剂设计中使用的反应性功能组的调查.
主要成果:
- 在临床发展的各个阶段识别了许多不可逆和可逆的共价抑制剂.
- 针对非氨酸氨基酸进行共价抑制的新兴趋势.
- 描述各种反应性组,使得共价键的形成.
结论:
- 协同抑制代表了蛋白质激酶药物发现的强大和不断扩展的方法.
- 化学策略的进步正在扩大可向残留物和抑制剂设计的范围.
- 该领域对未来的治疗开发具有显著的前景.
相关概念视频
Protein Kinases and Phosphatases
3.8K
3.8K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K


